Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.790
-0.140 (-7.25%)
At close: Feb 11, 2026, 4:00 PM EST
1.830
+0.040 (2.23%)
After-hours: Feb 11, 2026, 4:58 PM EST
Century Therapeutics Employees
As of December 31, 2024, Century Therapeutics had 150 total employees, including 140 full-time and 10 part-time employees. The number of employees decreased by 15 or -9.09% compared to the previous year.
Employees
150
Change (1Y)
-15
Growth (1Y)
-9.09%
Revenue / Employee
$755,580
Profits / Employee
-$176,547
Market Cap
321.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 150 | -15 | -9.09% | 140 | 10 |
| Dec 31, 2023 | 165 | -19 | -10.33% | 152 | 13 |
| Dec 31, 2022 | 184 | -4 | -2.13% | 163 | 21 |
| Dec 31, 2021 | 188 | 81 | 75.70% | 170 | 18 |
| Jun 30, 2021 | 121 | - | - | 121 | 0 |
| Mar 31, 2021 | 107 | - | - | 97 | 10 |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 299 |
| Allogene Therapeutics | 229 |
| Entrada Therapeutics | 183 |
| Puma Biotechnology | 172 |
| Adlai Nortye | 123 |
| Aura Biosciences | 109 |
| PepGen | 57 |
| Atea Pharmaceuticals | 56 |
IPSC News
- 2 days ago - Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
- 2 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 4 months ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 9 months ago - Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - GlobeNewsWire